NO995419L - Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpere - Google Patents
Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpereInfo
- Publication number
- NO995419L NO995419L NO995419A NO995419A NO995419L NO 995419 L NO995419 L NO 995419L NO 995419 A NO995419 A NO 995419A NO 995419 A NO995419 A NO 995419A NO 995419 L NO995419 L NO 995419L
- Authority
- NO
- Norway
- Prior art keywords
- testosterone
- administration
- drug delivery
- delivery devices
- precursors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE970333 | 1997-05-07 | ||
PCT/IE1998/000033 WO1998050016A2 (en) | 1997-05-07 | 1998-05-07 | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995419D0 NO995419D0 (no) | 1999-11-05 |
NO995419L true NO995419L (no) | 2000-01-07 |
Family
ID=11041465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995419A NO995419L (no) | 1997-05-07 | 1999-11-05 | Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forløpere |
Country Status (15)
Country | Link |
---|---|
US (1) | US6416780B1 (es) |
EP (1) | EP0981327B1 (es) |
JP (1) | JP2001524124A (es) |
CN (1) | CN1184957C (es) |
AT (1) | ATE227120T1 (es) |
AU (1) | AU741482B2 (es) |
CA (1) | CA2288046C (es) |
DE (1) | DE69809222T2 (es) |
DK (1) | DK0981327T3 (es) |
ES (1) | ES2187024T3 (es) |
IL (1) | IL132702A0 (es) |
NO (1) | NO995419L (es) |
NZ (1) | NZ501236A (es) |
PT (1) | PT981327E (es) |
WO (1) | WO1998050016A2 (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
WO2003080018A1 (en) * | 2002-03-27 | 2003-10-02 | Galen (Chemicals) Limited | Intravaginal matrix drug delivery devices |
US8399013B2 (en) | 2003-06-26 | 2013-03-19 | Poly-Med, Inc. | Partially absorbable fiber-reinforced composites for controlled drug delivery |
US8404272B2 (en) | 2003-06-26 | 2013-03-26 | Poly-Med, Inc. | Fiber-reinforced composite rings for intravaginal controlled drug delivery |
US7922702B2 (en) | 2004-07-02 | 2011-04-12 | Qlt Inc. | Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device |
AR056968A1 (es) | 2005-04-11 | 2007-11-07 | Xenon Pharmaceuticals Inc | Compuestos espiro-oxindol y composiciones farmacéuticas |
AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
WO2007021964A2 (en) | 2005-08-11 | 2007-02-22 | Massachusetts Institute Of Technology | Intravesical drug delivery device and method |
WO2007115261A2 (en) * | 2006-03-31 | 2007-10-11 | Qlt Plug Delivery, Inc. | Drug delivery methods, structures, and compositions for nasolacrimal system |
TW200833695A (en) | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Use of spiro-oxindole compounds as therapeutic agents |
WO2009076547A2 (en) | 2007-12-11 | 2009-06-18 | Massachusetts Institute Of Technology | Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens |
LT2249757T (lt) * | 2008-02-04 | 2017-09-25 | Ferring B.V. | Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai |
US9034365B2 (en) | 2008-05-20 | 2015-05-19 | Poly-Med, Inc. | Biostable, multipurpose, microbicidal intravaginal devices |
JP5908279B2 (ja) * | 2008-08-09 | 2016-04-26 | マサチューセッツ インスチテュート オブ テクノロジーMassachusetts Institute Of Technology | 移植可能な薬物送達デバイス並びに男性の尿生殖器及び周囲組織を治療する方法 |
CA2741024A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
CN103664973B (zh) | 2008-10-17 | 2017-04-19 | 泽农医药公司 | 螺羟吲哚化合物及其作为治疗剂的用途 |
US20110269788A1 (en) | 2008-12-29 | 2011-11-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole-derivatives as sodium channel blockers |
CA2947339A1 (en) | 2009-06-26 | 2010-12-29 | Heejin Lee | Implantable drug delivery devices and methods of making the same |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
NZ712378A (en) | 2009-10-14 | 2017-05-26 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
SG183126A1 (en) | 2010-02-26 | 2012-09-27 | Xenon Pharmaceuticals Inc | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
RU2620032C2 (ru) | 2011-01-10 | 2017-05-22 | Аллерган, Инк. | Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании |
KR20140048086A (ko) | 2011-02-04 | 2014-04-23 | 타리스 바이오메디컬 인코포레이티드 | 저 용해성 약물의 제어 방출을 위한 이식가능한 디바이스 |
US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
EP3290024B1 (en) | 2011-08-29 | 2019-04-17 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
JP6014154B2 (ja) | 2011-10-31 | 2016-10-25 | ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. | ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用 |
SG10201708522SA (en) | 2013-03-15 | 2017-12-28 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
CA2904444A1 (en) | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Dual reactivity potent kunitz inhibitor of fibrinolysis |
EP3035991B1 (en) | 2013-08-19 | 2020-07-08 | TARIS Biomedical LLC | Multi-unit drug delivery devices |
CN104546668B (zh) * | 2013-10-23 | 2019-03-05 | 国家卫生计生委科学技术研究所 | 液体硅橡胶为载体的药物缓控释系统的制备及应用 |
US9820994B2 (en) * | 2014-06-28 | 2017-11-21 | Laboratorios Andromaco S.A. | Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
US10894150B2 (en) | 2015-04-23 | 2021-01-19 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
AU2017220738B2 (en) | 2016-02-19 | 2022-02-24 | Phoenix Molecular Designs | Carboxamide derivatives useful as RSK inhibitors |
MX2018013985A (es) | 2016-05-20 | 2019-08-22 | Xenon Pharmaceuticals Inc | Compuestos de bencenosulfonamida y sus usos como agentes terapéuticos. |
CA3042004A1 (en) | 2016-12-09 | 2018-06-14 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
WO2019241533A1 (en) | 2018-06-13 | 2019-12-19 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
PE20211065A1 (es) | 2018-07-27 | 2021-06-09 | Xenon Pharmaceuticals Inc | Metodo para tratar la epilepsia |
WO2020047312A1 (en) | 2018-08-31 | 2020-03-05 | Xenon Pharmaceuticals Inc. | Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors |
EA202190395A1 (ru) | 2018-08-31 | 2021-06-15 | Ксенон Фармасьютикалз Инк. | Замещенные гетероарилом сульфонамидные соединения и их применение в качестве терапевтических средств |
US11813354B1 (en) | 2019-01-11 | 2023-11-14 | Shear Kershman Laboratories, Inc | Trans-mucosal delivery system for testosterone |
KR20210126077A (ko) | 2019-02-11 | 2021-10-19 | 피닉스 몰레큘라 디자인스 | Rsk 억제제의 결정형 |
KR20240070604A (ko) | 2021-09-24 | 2024-05-21 | 제논 파마슈티칼스 인크. | 소듐 채널 활성화제로서 피리디닐아세트아미드 유도체 |
US20230144095A1 (en) | 2021-09-24 | 2023-05-11 | Xenon Pharmaceuticals Inc. | Pyridine derivatives and their use as sodium channel activators |
IL311056A (en) | 2021-09-24 | 2024-04-01 | Xenon Pharmaceuticals Inc | Pyridine derivatives as sodium channel activators |
TW202404583A (zh) | 2022-06-08 | 2024-02-01 | 加拿大商再諾製藥公司 | 吡啶胺衍生物及其作為鉀通道調節劑之用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920805A (en) * | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
GB2079158B (en) * | 1980-06-09 | 1985-01-09 | Ahi Operations Ltd | Intra-vaginal devices |
US5340585A (en) * | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
IL116433A (en) * | 1994-12-19 | 2002-02-10 | Galen Chemicals Ltd | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS |
-
1998
- 1998-05-07 PT PT98921701T patent/PT981327E/pt unknown
- 1998-05-07 US US09/423,324 patent/US6416780B1/en not_active Expired - Lifetime
- 1998-05-07 IL IL13270298A patent/IL132702A0/xx not_active IP Right Cessation
- 1998-05-07 DK DK98921701T patent/DK0981327T3/da active
- 1998-05-07 CN CNB988049139A patent/CN1184957C/zh not_active Expired - Lifetime
- 1998-05-07 EP EP98921701A patent/EP0981327B1/en not_active Expired - Lifetime
- 1998-05-07 CA CA002288046A patent/CA2288046C/en not_active Expired - Fee Related
- 1998-05-07 AT AT98921701T patent/ATE227120T1/de not_active IP Right Cessation
- 1998-05-07 WO PCT/IE1998/000033 patent/WO1998050016A2/en active IP Right Grant
- 1998-05-07 ES ES98921701T patent/ES2187024T3/es not_active Expired - Lifetime
- 1998-05-07 AU AU74469/98A patent/AU741482B2/en not_active Expired
- 1998-05-07 NZ NZ501236A patent/NZ501236A/en not_active IP Right Cessation
- 1998-05-07 DE DE69809222T patent/DE69809222T2/de not_active Expired - Lifetime
- 1998-05-07 JP JP54787898A patent/JP2001524124A/ja active Pending
-
1999
- 1999-11-05 NO NO995419A patent/NO995419L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0981327A2 (en) | 2000-03-01 |
CA2288046C (en) | 2006-10-03 |
CN1184957C (zh) | 2005-01-19 |
CA2288046A1 (en) | 1998-11-12 |
DK0981327T3 (da) | 2003-03-10 |
AU741482B2 (en) | 2001-11-29 |
WO1998050016A2 (en) | 1998-11-12 |
ATE227120T1 (de) | 2002-11-15 |
WO1998050016A3 (en) | 1999-02-04 |
US6416780B1 (en) | 2002-07-09 |
NO995419D0 (no) | 1999-11-05 |
ES2187024T3 (es) | 2003-05-16 |
DE69809222D1 (de) | 2002-12-12 |
EP0981327B1 (en) | 2002-11-06 |
NZ501236A (en) | 2002-02-01 |
JP2001524124A (ja) | 2001-11-27 |
DE69809222T2 (de) | 2003-08-14 |
IL132702A0 (en) | 2001-03-19 |
AU7446998A (en) | 1998-11-27 |
CN1255056A (zh) | 2000-05-31 |
PT981327E (pt) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995419D0 (no) | Intravaginale anordninger for legemiddelavlevering for administrering av testosteron og testosteron-forlöpere | |
AU1227899A (en) | Osmotic medicament releasing system | |
GB2341550A (en) | Gastroretentive controlled release microspheres for improved drug delivery | |
WO2003077972A3 (en) | Implantable drug delivery system | |
WO2003028660A3 (en) | Drug delivery devices and methods | |
ES2192226T3 (es) | Composicion farmaceutica oral que contiene agentes activos antimicrobianos y pantoprazol de liberacion prolongada. | |
GB2338414A (en) | Intravesical drug delivery system | |
ID21259A (id) | Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif | |
BR0215262A (pt) | Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas | |
EP1504758A3 (en) | Controlled-release formulations coated with aqueous dispersions of ethylcellulose | |
AU4399196A (en) | Intravaginal drug delivery devices for the administration of 17beta -oestradiol precursors | |
PT1017391E (pt) | Formulacao de comprimidos de libertacao prolongada para tratar a doenca de parkinson | |
AR036972A1 (es) | Tableta bioadhesiva de hidratacion progresiva y liberacion sostenida y su uso en la fabricacion de un agente farmaceutico | |
EP1499300A4 (en) | PHARMACEUTICAL FORMULATIONS WITH IMPROVED BIOAVAILABILITY | |
ATE391495T1 (de) | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe | |
HK1032010A1 (en) | Medicament formulation with a controlled release of an active agent. | |
WO1998026767A3 (en) | Site-specific controlled release dosage formulation for mesalamine | |
AU1495595A (en) | Sustained-release dosage forms of alfuzosin hydrochloride | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
HK1060691A1 (en) | Ion-strength independent sustained release pharmaceutical formulation | |
WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
BG106342A (en) | Low-dose tablets and preparation method | |
WO1998038985A3 (en) | Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases | |
PT8662T (pt) | Doseador para distribuir um medicamento inoforo aplicado em especial para tratamento de animais | |
Torres | Long-term follow-up of early AZT use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |